BEAM logo

Beam Therapeutics (BEAM) Cash from investing

annual CFI:

$185.01M+$113.17M(+157.53%)
December 31, 2024

Summary

  • As of today (June 28, 2025), BEAM annual cash flow from investing activities is $185.01 million, with the most recent change of +$113.17 million (+157.53%) on December 31, 2024.
  • During the last 3 years, BEAM annual CFI has risen by +$479.15 million (+162.90%).
  • BEAM annual CFI is now at all-time high.

Performance

BEAM Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

quarterly CFI:

-$125.09M-$251.37M(-199.06%)
March 31, 2025

Summary

  • As of today (June 28, 2025), BEAM quarterly cash flow from investing activities is -$125.09 million, with the most recent change of -$251.37 million (-199.06%) on March 31, 2025.
  • Over the past year, BEAM quarterly CFI has dropped by -$71.63 million (-133.97%).
  • BEAM quarterly CFI is now -199.06% below its all-time high of $126.28 million, reached on December 31, 2024.

Performance

BEAM quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

TTM CFI:

$113.38M-$71.63M(-38.71%)
March 31, 2025

Summary

  • As of today (June 28, 2025), BEAM TTM cash flow from investing activities is $113.38 million, with the most recent change of -$71.63 million (-38.71%) on March 31, 2025.
  • Over the past year, BEAM TTM CFI has increased by +$120.46 million (+1702.57%).
  • BEAM TTM CFI is now -38.71% below its all-time high of $185.01 million, reached on December 31, 2024.

Performance

BEAM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BEAM Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+157.5%-134.0%+1702.6%
3 y3 years+162.9%+76.7%+120.5%
5 y5 years+377.5%-62.9%+180.4%

BEAM Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+140.1%-199.1%+76.7%-38.7%+117.4%
5 y5-yearat high+140.1%-199.1%+76.7%-38.7%+117.4%
alltimeall timeat high+140.1%-199.1%+76.7%-38.7%+117.4%

BEAM Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$125.09M(-199.1%)
$113.38M(-38.7%)
Dec 2024
$185.01M(+157.5%)
$126.28M(+411.3%)
$185.01M(+18.0%)
Sep 2024
-
$24.70M(-71.8%)
$156.83M(+28.7%)
Jun 2024
-
$87.49M(-263.6%)
$121.90M(-1822.9%)
Mar 2024
-
-$53.46M(-154.5%)
-$7.08M(-109.8%)
Dec 2023
$71.84M(-115.6%)
$98.10M(-1058.9%)
$71.84M(-17.6%)
Sep 2023
-
-$10.23M(-75.3%)
$87.18M(+42.4%)
Jun 2023
-
-$41.48M(-263.0%)
$61.24M(-39.6%)
Mar 2023
-
$25.45M(-77.6%)
$101.45M(-122.0%)
Dec 2022
-$461.34M(+56.8%)
$113.44M(-413.6%)
-$461.34M(-29.3%)
Sep 2022
-
-$36.17M(+2766.4%)
-$652.27M(+20.8%)
Jun 2022
-
-$1.26M(-99.8%)
-$539.98M(-2.2%)
Mar 2022
-
-$537.34M(+593.4%)
-$551.86M(+87.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$294.14M(+193.8%)
-$77.50M(-201.8%)
-$294.14M(-1.3%)
Sep 2021
-
$76.11M(-679.4%)
-$298.07M(-12.1%)
Jun 2021
-
-$13.14M(-95.3%)
-$338.96M(+11.9%)
Mar 2021
-
-$279.63M(+243.4%)
-$302.96M(+202.6%)
Dec 2020
-$100.12M(+50.2%)
-$81.43M(-331.1%)
-$100.12M(+4585.2%)
Sep 2020
-
$35.23M(+54.0%)
-$2.14M(-90.8%)
Jun 2020
-
$22.87M(-129.8%)
-$23.15M(-83.6%)
Mar 2020
-
-$76.79M(-563.7%)
-$141.10M(+111.7%)
Dec 2019
-$66.66M(+396.6%)
$16.56M(+16.5%)
-$66.66M(-19.9%)
Sep 2019
-
$14.21M(-114.9%)
-$83.22M(-14.6%)
Jun 2019
-
-$95.08M(+3939.0%)
-$97.43M(+4039.0%)
Mar 2019
-
-$2.35M
-$2.35M
Dec 2018
-$13.42M
-
-

FAQ

  • What is Beam Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Beam Therapeutics?
  • What is Beam Therapeutics annual CFI year-on-year change?
  • What is Beam Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Beam Therapeutics?
  • What is Beam Therapeutics quarterly CFI year-on-year change?
  • What is Beam Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Beam Therapeutics?
  • What is Beam Therapeutics TTM CFI year-on-year change?

What is Beam Therapeutics annual cash flow from investing activities?

The current annual CFI of BEAM is $185.01M

What is the all time high annual CFI for Beam Therapeutics?

Beam Therapeutics all-time high annual cash flow from investing activities is $185.01M

What is Beam Therapeutics annual CFI year-on-year change?

Over the past year, BEAM annual cash flow from investing activities has changed by +$113.17M (+157.53%)

What is Beam Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of BEAM is -$125.09M

What is the all time high quarterly CFI for Beam Therapeutics?

Beam Therapeutics all-time high quarterly cash flow from investing activities is $126.28M

What is Beam Therapeutics quarterly CFI year-on-year change?

Over the past year, BEAM quarterly cash flow from investing activities has changed by -$71.63M (-133.97%)

What is Beam Therapeutics TTM cash flow from investing activities?

The current TTM CFI of BEAM is $113.38M

What is the all time high TTM CFI for Beam Therapeutics?

Beam Therapeutics all-time high TTM cash flow from investing activities is $185.01M

What is Beam Therapeutics TTM CFI year-on-year change?

Over the past year, BEAM TTM cash flow from investing activities has changed by +$120.46M (+1702.57%)
On this page